Marina Biotech Inc. / Dendreon Corp. / Mirna Therapeutics Inc. / Novosom AG / Kala / Okairos AG / Gradalis Inc. / ProNAi / Debiopharm Group / Apjohn Ventures / /
Country
Switzerland / Germany / /
Currency
cent / USD / /
Event
FDA Phase / Funding / M&A / Business Partnership / /
Facility
See Marina / National Eye Institute / Blood Institute / Mirna’s pipeline / National Institute of Allergy / /
IndustryTerm
treatment for cystic fibrosis / delivery technology / cancer therapeutics / liposomal delivery technology / savvy technology purchase / hepatitis C treatment / chemical modifications / /
MedicalCondition
extrahepatic tumor / preclinical tumor / bladder cancer / familial adenomatous polyposis / next-generation hepatitis C / II personalized cancer / additional disease / cystic fibrosis-related infection / cystic fibrosis / chronic HCV infection / genetics diseases / II Cancer Vaccine By Trista Morrison Staff Writer Cancer / precancerous syndrome / cancer / microRNA tumor / advanced solid tumors / HCV / complex / proliferative diseases / HCV infection / diseases / preventive hepatitis C / inflammation / /
MedicalTreatment
cancer therapeutics / /
Organization
National Eye Institute / National Heart / Lung / and Blood Institute / National Institute of Allergy and Infectious Diseases / /
Person
Mari Serebrov Washington / J. Michael French / Wendi V. Rodrigueza / Kevin Pojasik / Cancer Vaccine By Trista Morrison / David Shanahan / Mina Sooch / / /
Position
Editor / general partner / Marie Powers Staff Writer / vice president of product development / Catherine Shaffer Staff Writer / messenger / vice president of corporate development / president / CEO and cofounder / president and CEO / Trista Morrison Staff Writer / member / board / /
Product
Smarticles / PNT2258 / personalized cancer vaccine / Cancer Vaccine / ProCvax vaccine / /
BIOTECH’S MOST RESPECTED NEWS SOURCE FOR MORE THAN 20 YEARS THURSDAY MARCH 15, 2012 VOLUME 23 , NO. 51